Akèy › Sakòm Selil Dendritik Entèdigitan
Etid klinik pou Sakòm Selil Dendritik Entèdigitan ap rekrite nan Etazini
7 etid pou Sakòm Selil Dendritik Entèdigitan ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Ap rekriteFaz 1
1 Day – 21 Years · Tout sèks · Mizajou Aug 26, 2026 · NCT05857969This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07121946SynKIR-310 for Relapsed/Refractory B-NHL
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06544265Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 23, 2026 · NCT06846463A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT06736613Q702 for the Treatment of Patients With Hematologic Malignancies
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 10, 2025 · NCT06712810Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 9, 2025 · NCT05940272Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.